Skip to main content
×
Home
    • Aa
    • Aa
  • The International Journal of Neuropsychopharmacology, Volume 13, Issue 10
  • November 2010, pp. 1369-1381

Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients

  • Roosmarijn C. Drexhage (a1), Leonie van der Heul-Nieuwenhuijsen (a1), Roos C. Padmos (a1), Nico van Beveren (a2), Dan Cohen (a3) (a4), Marjan A. Versnel (a1), Willem A. Nolen (a5) and Hemmo A. Drexhage (a1)
  • DOI: http://dx.doi.org/10.1017/S1461145710000799
  • Published online: 15 July 2010
Abstract
Abstract

Accumulating evidence indicates an activated inflammatory response system as a vulnerability factor for schizophrenia (SZ) and bipolar disorder (BD). We aimed to detect a specific inflammatory monocyte gene expression signature in SZ and compare such signature with our recently described inflammatory monocyte gene signature in BD. A quantitative-polymerase chain reaction (Q-PCR) case-control gene expression study was performed on monocytes of 27 SZ patients and compared to outcomes collected in 56 BD patients (all patients naturalistically treated). For Q-PCR we used nine ‘SZ specific genes’ (found in whole genome analysis), the 19 BD signature genes (previously found by us) and six recently described autoimmune diabetes inflammatory monocyte genes. Monocytes of SZ patients had (similar to those of BD patients) a high inflammatory set point composed of three subsets of strongly correlating genes characterized by different sets of transcription/MAPK regulating factors. Subset 1A, characterized by ATF3 and DUSP2, and subset 1B, characterized by EGR3 and MXD1, were shared between BD and SZ patients (up-regulated in 67% and 51%, and 34% and 41%, respectively). Subset 2, characterized by PTPN7 and NAB2 was up-regulated in the monocytes of 62% BD, but down-regulated in the monocytes of 48% of SZ patients. Our approach shows that monocytes of SZ and BD patients overlap, but also differ in inflammatory gene expression. Our approach opens new avenues for nosological classifications of psychoses based on the inflammatory state of patients, enabling selection of those patients who might benefit from an anti-inflammatory treatment.

Copyright
Corresponding author
Address for correspondence: R. C. Drexhage, M.D., Department of Immunology, Erasmus MC, PO Box 2040, 3000CA Rotterdam, The Netherlands. Tel.: 0031 10 7044091Fax: 0031 10 7044731Email: r.drexhage@erasmusmc.nl
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

S Akhondzadeh , M Tabatabaee , H Amini , SA Ahmadi Abhari , (2007). Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial. Schizophrenia Research 90, 179185.

NC Andreasen , M Flaum , S Arndt (1992). The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Archives of General Psychiatry 49, 615623.

DE Ayer , RN Eisenman (1993). A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. Genes & Development 7, 21102119.

E Beillard , N Pallisgaard , VH van der Velden , W Bi , (2003). Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program. Leukemia 17, 24742486.

AB Birkenaes , S Opjordsmoen , C Brunborg , JA Engh , (2007). The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study. Journal of Clinical Psychiatry 68, 917923.

V Blank (2008). Small Maf proteins in mammalian gene control: mere dimerization partners or dynamic transcriptional regulators? Journal of Molecular Biology 376, 913925.

E Bramon , PC Sham (2001). The common genetic liability between schizophrenia and bipolar disorder: a review. Current Psychiatry Reports 3, 332337.

JH Carter , WG Tourtellotte (2007). Early growth response transcriptional regulators are dispensable for macrophage differentiation. Journal of Immunology 178, 30383047.

S Collins , MA Lutz , PE Zarek , RA Anders , (2008). Opposing regulation of T cell function by Egr-1/NAB2 and Egr-2/Egr-3. European Journal of Immunology 38, 528536.

D de Ridder , FJ Staal , JJ van Dongen , MJ Reinders (2006). Maximum significance clustering of oligonucleotide microarrays. Bioinformatics 22, 326331.

RC Drexhage , RC Padmos , H de Wit , MA Versnel , (2008). Patients with schizophrenia show raised serum levels of the pro-inflammatory chemokine CCL2: association with the metabolic syndrome in patients? Schizophrenia Research 102, 352355.

L Drzyzga , E Obuchowicz , A Marcinowska , ZS Herman (2006). Cytokines in schizophrenia and the effects of antipsychotic drugs. Brain, Behaviour and Immunity 20, 532545.

WW Eaton , M Byrne , H Ewald , O Mors , (2006). Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. American Journal of Psychiatry 163, 521528.

PJ Hurlin , J Huang (2006). The MAX-interacting transcription factor network. Seminars in Cancer Biology 16, 265274.

EM Knijff , MN Breunis , MC van Geest , RW Kupka , (2006). A relative resistance of T cells to dexamethasone in bipolar disorder. Bipolar Disorder 8, 740750.

P Lichtenstein , BH Yip , C Bjork , Y Pawitan , (2009). Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 373, 234239.

PA Lyons , M Koukoulaki , A Hatton , K Doggett , (2007). Microarray analysis of human leucocyte subsets: the advantages of positive selection and rapid purification. BMC Genomics 8, 64.

SD Martina , MS Ismail , KS Vesta (2006). Cilomilast: orally active selective phosphodiesterase-4 inhibitor for treatment of chronic obstructive pulmonary disease. Annals of Pharmacotherapy 40, 18221828.

H Motohashi , JA Shavit , K Igarashi , M Yamamoto , (1997). The world according to Maf. Nucleic Acids Research 25, 29532959.

N Muller , MJ Schwarz , S Dehning , A Douhe , (2006). The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Molecular Psychiatry 11, 680684.

N Muller , M Ulmschneider , C Scheppach , MJ Schwarz , (2004). COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy. European Archives of Psychiatry & Clinical Neuroscience 254, 1422.

AM Myint , HW Steinbusch , L Goeghegan , D Luchtman , (2007). Effect of the COX-2 inhibitor celecoxib on behavioural and immune changes in an olfactory bulbectomised rat model of depression. Neuroimmunomodulation 14, 6571.

FG Nery , ES Monkul , JP Hatch , M Fonseca , (2008). Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study. Human Psychopharmacology 23, 8794.

MJ Owen , N Craddock (2009). Diagnosis of functional psychoses: time to face the future. Lancet 373, 190191.

RC Padmos , L Bekris , EM Knijff , H Tiemeier , (2004). A high prevalence of organ-specific autoimmunity in patients with bipolar disorder. Biological Psychiatry 56, 476482.

RC Padmos , MH Hillegers , EM Knijff , R Vonk , (2008 a). A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Archives of General Psychiatry 65, 395407.

RC Padmos , NC Schloot , H Beyan , C Ruwhof , (2008 b). Distinct monocyte gene-expression profiles in autoimmune diabetes. Diabetes 57, 27682773.

T Pollmacher , M Haack , A Schuld , T Kraus , (2000). Effects of antipsychotic drugs on cytokine networks. Journal of Psychiatric Research 34, 369382.

RS Smith , M Maes (1995). The macrophage-T-lymphocyte theory of schizophrenia: additional evidence. Medical Hypotheses 45, 135141.

FJ Staal , F Weerkamp , MR Baert , CM van den Burg , (2004). Wnt target genes identified by DNA microarrays in immature CD34+ thymocytes regulate proliferation and cell adhesion. Journal of Immunology 172, 10991108.

T Suppes , GS Leverich , PE Keck , WA Nolen , (2001). The stanley foundation bipolar treatment outcome network. II. Demographics and illness characteristics of the first 261 patients. Journal of Affective Disorders 67, 4559.

PA Thomson , NR Wray , JK Millar , KL Evans , (2005). Association between the TRAX/DISC locus and both bipolar disorder and schizophrenia in the Scottish population. Molecular Psychiatry 10, 657668, 616.

S Tyring , A Gottlieb , K Papp , K Gordon , (2006). Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 367, 2935.

R Vonk , AC van der Schot , RS Kahn , WA Nolen , (2007). Is autoimmune thyroiditis part of the genetic vulnerability (or an endophenotype) for bipolar disorder? Biological Psychiatry 62, 135140.

J Zhu , E Mix , B Winblad (2001). The antidepressant and antiinflammatory effects of rolipram in the central nervous system. CNS Drug Reviews 7, 387398.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The International Journal of Neuropsychopharmacology
  • ISSN: 1461-1457
  • EISSN: 1469-5111
  • URL: /core/journals/the-international-journal-of-neuropsychopharmacology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Type Description Title
UNKNOWN
Supplementary Materials

Drexhage supplementary material
Table 2.doc

 Unknown (31 KB)
31 KB
UNKNOWN
Supplementary Materials

Drexhage supplementary material
Table 1.doc

 Unknown (37 KB)
37 KB
UNKNOWN
Supplementary Materials

Drexhage supplementary material
Figure 1 legend.doc

 Unknown (20 KB)
20 KB
UNKNOWN
Supplementary Materials

Drexhage supplementary material
Figure 1.jpg

 Unknown (263 KB)
263 KB